These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 16507405)

  • 1. Tumor angiogenesis and therapy.
    Cao Y
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S340-3. PubMed ID: 16507405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of selected patents for cancer therapy targeting tumor angiogenesis.
    Kirstein MN; Moore MM; Dudek AZ
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):153-61. PubMed ID: 18221033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic cancer therapy.
    Cao Y
    Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis.
    Cao Y; Liu Q
    Adv Cancer Res; 2007; 97():203-24. PubMed ID: 17419947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis inhibitors and the need for anti-angiogenic therapeutics.
    Dass CR; Tran TM; Choong PF
    J Dent Res; 2007 Oct; 86(10):927-36. PubMed ID: 17890668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Numerical simulation of the inhibitory effect of angiostatin on metastatic tumor angiogenesis and microenvironment.
    Zhao G; Yan W; Chen E; Yu X; Cai W
    Bull Math Biol; 2013 Feb; 75(2):274-87. PubMed ID: 23292363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic effects of marine sponge derived compounds on cancer.
    Senthilkumar K; Venkatesan J; Manivasagan P; Kim SK
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):1097-108. PubMed ID: 24148290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic therapy for the treatment of pediatric solid malignancies.
    Davidoff AM; Kandel JJ
    Semin Pediatr Surg; 2004 Feb; 13(1):53-60. PubMed ID: 14765371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor angiogenesis inhibitors.
    Kiselev SM; Lutsenko SV; Severin SE; Severin ES
    Biochemistry (Mosc); 2003 May; 68(5):497-513. PubMed ID: 12882631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model.
    Jain RK; Tong RT; Munn LL
    Cancer Res; 2007 Mar; 67(6):2729-35. PubMed ID: 17363594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of angiogenesis in tumor growth and metastasis.
    Folkman J
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiogenesis, lymphangiogenesis, and tumor progression].
    Hawighorst T
    Zentralbl Gynakol; 2002 Nov; 124(11):497-505. PubMed ID: 12796842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
    Wilson PM; LaBonte MJ; Lenz HJ
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
    Roukos DH; Tzakos A; Zografos G
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer.
    Shanmugam MK; Warrier S; Kumar AP; Sethi G; Arfuso F
    Curr Vasc Pharmacol; 2017; 15(6):503-519. PubMed ID: 28707601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenesis drug design: multiple pathways targeting tumor vasculature.
    Zhong H; Bowen JP
    Curr Med Chem; 2006; 13(8):849-62. PubMed ID: 16611071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of molecular and functional alterations of tumor endothelial cells to design anti-angiogenic strategies.
    Bussolati B; Deregibus MC; Camussi G
    Curr Vasc Pharmacol; 2010 Mar; 8(2):220-32. PubMed ID: 19485921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer.
    Bertolini F; Marighetti P; Martin-Padura I; Mancuso P; Hu-Lowe DD; Shaked Y; D'Onofrio A
    Drug Discov Today; 2011 Dec; 16(23-24):1052-60. PubMed ID: 21875682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism and its regulation of tumor-induced angiogenesis.
    Gupta MK; Qin RY
    World J Gastroenterol; 2003 Jun; 9(6):1144-55. PubMed ID: 12800214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.